Share Price and Basic Stock Data
Last Updated: January 27, 2026, 10:10 pm
| PEG Ratio | 39.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Covidh Technologies Ltd operates in the IT Consulting & Software sector, currently priced at ₹22.3 with a market capitalization of ₹18.8 Cr. The company has faced significant challenges, as evidenced by its reported sales, which have consistently stood at ₹0.00 from September 2022 through to the trailing twelve months ending in March 2025. This lack of revenue generation is concerning, especially given the competitive nature of the IT consulting industry, where many firms report substantial revenues. Covidh’s sales figures reflect an inability to capitalize on market opportunities, contrasting sharply with typical sector expectations, where companies often achieve revenues in the range of several crores. The absence of sales, coupled with a high P/E ratio of 125, raises questions about investor sentiment and market confidence in the company’s future performance.
Profitability and Efficiency Metrics
The profitability metrics of Covidh Technologies Ltd are troubling, with a reported net profit of ₹0.15 Cr, indicating a profit margin that is significantly below industry standards. The company reported negative operating profits across multiple quarters, peaking at ₹-0.11 Cr for both March 2022 and March 2023. Furthermore, the operating profit margin (OPM) for the latest fiscal year is not available, suggesting ongoing operational inefficiencies. The return on capital employed (ROCE) stood at 19.05% for the year ending March 2025, which is relatively strong compared to the sector average, but the overall profitability remains compromised due to lack of revenue. The interest coverage ratio (ICR) of -0.24x indicates that the company is struggling to meet its interest obligations, raising concerns about its financial health and operational sustainability.
Balance Sheet Strength and Financial Ratios
Covidh’s balance sheet presents a mixed picture, with total borrowings reported at ₹1.62 Cr and reserves at ₹-0.43 Cr, indicating a negative equity position. The company’s long-term debt-to-equity ratio of 58.39x is alarmingly high, suggesting excessive leverage, which could pose significant risks in times of financial stress. The current ratio of 2.62x indicates that the company has a strong short-term liquidity position, potentially allowing it to meet immediate liabilities despite its negative reserves. However, the price-to-book value (P/BV) ratio of 6.13x highlights a significant premium over the book value per share, raising questions about the sustainability of this valuation amidst ongoing operational challenges. The enterprise value (EV) of ₹-1.33 Cr further complicates the financial outlook, indicating that the market perceives significant risks associated with the company’s ability to generate future cash flows.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Covidh Technologies Ltd reflects a significant shift in investor confidence, with promoters holding 3.57% of the shares as of November 2025, down from 100% earlier in the year. This drastic reduction in promoter holdings suggests a loss of confidence among the company’s founders or primary stakeholders. In contrast, public shareholding has surged to 96.44%, indicating an increase in retail investor participation. The total number of shareholders has also increased to 1,031, which may imply growing interest or speculative trading in the stock. However, the volatility in shareholding raises concerns about long-term commitment from institutional investors, as there are no foreign or domestic institutional investors currently reported. This dilution of promoter stake could lead to further uncertainty regarding strategic direction and operational oversight.
Outlook, Risks, and Final Insight
The outlook for Covidh Technologies Ltd remains uncertain due to its persistent lack of revenue generation and high leverage. The company faces significant risks, including operational inefficiencies, a high debt burden, and dwindling promoter confidence, which could hinder its ability to attract further investment. Conversely, the relatively strong ROCE and liquidity ratios could provide a foundation for recovery, should the company successfully pivot its business strategy or identify new revenue streams. The upcoming quarters will be critical in determining whether Covidh can stabilize its operations and return to profitability. A successful turnaround could potentially rebuild investor trust and stabilize share prices, while failure to address these core issues may lead to further declines in market confidence and financial viability in an already challenging economic environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 58.1 Cr. | 18.4 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 133 Cr. | 123 | 194/99.8 | 20.3 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 49.4 Cr. | 386 | 388/140 | 30.9 | 26.7 | 0.26 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.89 Cr. | 1.28 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,891.88 Cr | 527.40 | 77.87 | 123.68 | 0.60% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.06 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.07 | 0.01 | 0.01 | 0.07 | 0.04 | 0.02 | 0.00 |
| Operating Profit | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | -0.04 | -0.02 | 0.00 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 |
| EPS in Rs | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.08 | -0.01 | -0.01 | -0.08 | 0.27 | -0.02 | 0.01 |
Last Updated: December 27, 2025, 10:31 am
Below is a detailed analysis of the quarterly data for Covidh Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.00 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.00 Cr., marking an increase of 0.02 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.01. The value appears strong and on an upward trend. It has increased from -0.02 (Jun 2025) to 0.01, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.32 | 10.90 | 25.50 | 21.36 | 28.92 | 12.30 | 2.13 | 2.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 23.14 | 10.28 | 25.14 | 20.92 | 28.46 | 11.98 | 2.19 | 0.19 | 0.11 | 0.11 | 0.09 | 0.13 | 0.13 |
| Operating Profit | 0.18 | 0.62 | 0.36 | 0.44 | 0.46 | 0.32 | -0.06 | 1.94 | -0.11 | -0.11 | -0.09 | -0.13 | -0.13 |
| OPM % | 0.77% | 5.69% | 1.41% | 2.06% | 1.59% | 2.60% | -2.82% | 91.08% | |||||
| Other Income | 0.00 | 0.00 | -12.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.28 |
| Interest | 0.00 | 0.00 | 0.16 | 0.20 | 0.27 | 0.23 | 0.22 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.50 | 0.08 | 0.21 | 0.15 | 0.08 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.08 | 0.12 | -12.49 | 0.03 | 0.04 | 0.01 | -0.40 | 1.80 | -0.11 | -0.11 | -0.09 | 0.14 | 0.15 |
| Tax % | 50.00% | 0.00% | 0.40% | 100.00% | 25.00% | 200.00% | 5.00% | 1.11% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | 0.04 | 0.12 | -12.54 | 0.00 | 0.04 | -0.02 | -0.42 | 1.78 | -0.11 | -0.11 | -0.09 | 0.14 | 0.15 |
| EPS in Rs | 0.00 | 0.00 | -0.46 | 0.00 | 0.00 | -0.00 | -0.02 | 0.06 | -0.00 | -0.00 | -0.11 | 0.17 | 0.18 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -10550.00% | 100.00% | -150.00% | -2000.00% | 523.81% | -106.18% | 0.00% | 18.18% | 255.56% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10750.00% | 10650.00% | -250.00% | -1850.00% | 2523.81% | -629.99% | 106.18% | 18.18% | 237.37% |
Covidh Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 18% |
| 3 Years: | 48% |
| TTM: | 218% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | % |
| 3 Years: | 60% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 10, 2025, 4:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 0.30 | 0.30 | 0.32 | 0.32 | 0.32 |
| Reserves | 2.33 | 2.44 | -10.10 | -10.09 | -10.05 | -10.07 | -10.49 | -10.71 | -0.31 | -0.42 | -0.54 | -0.42 | -0.43 |
| Borrowings | 4.28 | 4.97 | 6.15 | 6.83 | 7.49 | 7.53 | 6.56 | 2.02 | 0.00 | 0.13 | 0.18 | 1.61 | 1.62 |
| Other Liabilities | 3.56 | 2.54 | 4.61 | 5.57 | 8.19 | 4.12 | 3.81 | 2.59 | 0.02 | 0.04 | 0.10 | 0.05 | 0.04 |
| Total Liabilities | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
| Fixed Assets | 4.75 | 6.65 | 0.48 | 0.44 | 0.45 | 0.75 | 0.62 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 3.08 | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.32 | 4.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 8.62 | 7.74 | 10.78 | 12.47 | 15.78 | 11.43 | 9.86 | 4.07 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
| Total Assets | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
Below is a detailed analysis of the balance sheet data for Covidh Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 0.32 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.32 Cr..
- For Reserves, as of Sep 2025, the value is -0.43 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -0.42 Cr. (Mar 2025) to -0.43 Cr., marking a decline of 0.01 Cr..
- For Borrowings, as of Sep 2025, the value is 1.62 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 1.61 Cr. (Mar 2025) to 1.62 Cr., marking an increase of 0.01 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing). It has decreased from 0.05 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1.55 Cr.. The value appears to be improving (decreasing). It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
- For Total Assets, as of Sep 2025, the value is 1.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
However, the Borrowings (1.62 Cr.) are higher than the Reserves (-0.43 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.10 | -4.35 | -5.79 | -6.39 | -7.03 | -7.21 | -6.62 | -0.08 | -0.11 | -0.24 | -0.27 | -1.74 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Working Capital Days | 79.35 | 174.46 | 65.13 | 91.59 | 73.58 | 170.33 | 1,041.88 | 260.47 | ||||
| ROCE % | 0.51% | 0.68% | 2.27% | 3.29% | 4.03% | 2.98% | -2.44% | 42.42% | -11.58% | 19.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| Diluted EPS (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| Cash EPS (Rs.) | -0.27 | 0.07 | 0.18 | 0.21 | -12.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.10 | 0.46 | 0.50 | 0.49 | 0.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.10 | 0.46 | 0.50 | 0.49 | 0.52 |
| Revenue From Operations / Share (Rs.) | 2.01 | 24.23 | 31.67 | 22.68 | 24.05 |
| PBDIT / Share (Rs.) | -0.05 | 0.45 | 0.44 | 0.43 | 0.19 |
| PBIT / Share (Rs.) | -0.16 | 0.34 | 0.26 | 0.19 | 0.06 |
| PBT / Share (Rs.) | -0.37 | -0.01 | 0.01 | 0.00 | 0.06 |
| Net Profit / Share (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| NP After MI And SOA / Share (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| PBDIT Margin (%) | -2.57 | 1.86 | 1.40 | 1.92 | 0.79 |
| PBIT Margin (%) | -8.34 | 1.40 | 0.84 | 0.84 | 0.25 |
| PBT Margin (%) | -18.79 | -0.07 | 0.04 | 0.00 | 0.25 |
| Net Profit Margin (%) | -19.64 | -0.16 | 0.02 | -0.14 | -52.63 |
| NP After MI And SOA Margin (%) | -19.64 | -0.16 | 0.02 | -0.14 | -52.63 |
| Return on Networth / Equity (%) | -372.77 | -8.99 | 1.44 | -6.72 | -2425.18 |
| Return on Capital Employeed (%) | -2.65 | 4.20 | 3.42 | 2.63 | 1.00 |
| Return On Assets (%) | -4.00 | -0.24 | 0.03 | -0.20 | -92.73 |
| Long Term Debt / Equity (X) | 58.39 | 16.75 | 14.75 | 13.84 | 10.66 |
| Total Debt / Equity (X) | 58.39 | 22.04 | 18.07 | 16.79 | 13.57 |
| Asset Turnover Ratio (%) | 0.15 | 0.76 | 1.75 | 1.56 | 1.41 |
| Current Ratio (X) | 2.62 | 1.84 | 1.66 | 1.78 | 1.72 |
| Quick Ratio (X) | 2.62 | 1.84 | 1.66 | 1.78 | 1.72 |
| Interest Coverage Ratio (X) | -0.24 | 1.26 | 1.75 | 2.26 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | -0.87 | 0.88 | 1.03 | 0.82 | 0.00 |
| Enterprise Value (Cr.) | -1.33 | 10.82 | 11.01 | 11.58 | 13.81 |
| EV / Net Operating Revenue (X) | -0.62 | 0.42 | 0.32 | 0.48 | 0.54 |
| EV / EBITDA (X) | 24.26 | 22.58 | 23.32 | 25.02 | 68.50 |
| MarketCap / Net Operating Revenue (X) | 0.32 | 0.02 | 0.04 | 0.11 | 0.24 |
| Price / BV (X) | 6.13 | 1.25 | 2.86 | 5.56 | 11.48 |
| Price / Net Operating Revenue (X) | 0.32 | 0.02 | 0.04 | 0.11 | 0.24 |
| EarningsYield | -0.60 | -0.07 | 0.00 | -0.01 | -2.12 |
After reviewing the key financial ratios for Covidh Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 5. It has decreased from -0.04 (Mar 24) to -0.39, marking a decrease of 0.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 5. It has decreased from -0.04 (Mar 24) to -0.39, marking a decrease of 0.35.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.27. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to -0.27, marking a decrease of 0.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.10. It has decreased from 0.46 (Mar 24) to 0.10, marking a decrease of 0.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.10. It has decreased from 0.46 (Mar 24) to 0.10, marking a decrease of 0.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.01. It has decreased from 24.23 (Mar 24) to 2.01, marking a decrease of 22.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has decreased from 0.45 (Mar 24) to -0.05, marking a decrease of 0.50.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 0. It has decreased from 0.34 (Mar 24) to -0.16, marking a decrease of 0.50.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 0. It has decreased from -0.01 (Mar 24) to -0.37, marking a decrease of 0.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 2. It has decreased from -0.04 (Mar 24) to -0.39, marking a decrease of 0.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 2. It has decreased from -0.04 (Mar 24) to -0.39, marking a decrease of 0.35.
- For PBDIT Margin (%), as of Mar 25, the value is -2.57. This value is below the healthy minimum of 10. It has decreased from 1.86 (Mar 24) to -2.57, marking a decrease of 4.43.
- For PBIT Margin (%), as of Mar 25, the value is -8.34. This value is below the healthy minimum of 10. It has decreased from 1.40 (Mar 24) to -8.34, marking a decrease of 9.74.
- For PBT Margin (%), as of Mar 25, the value is -18.79. This value is below the healthy minimum of 10. It has decreased from -0.07 (Mar 24) to -18.79, marking a decrease of 18.72.
- For Net Profit Margin (%), as of Mar 25, the value is -19.64. This value is below the healthy minimum of 5. It has decreased from -0.16 (Mar 24) to -19.64, marking a decrease of 19.48.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -19.64. This value is below the healthy minimum of 8. It has decreased from -0.16 (Mar 24) to -19.64, marking a decrease of 19.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is -372.77. This value is below the healthy minimum of 15. It has decreased from -8.99 (Mar 24) to -372.77, marking a decrease of 363.78.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.65. This value is below the healthy minimum of 10. It has decreased from 4.20 (Mar 24) to -2.65, marking a decrease of 6.85.
- For Return On Assets (%), as of Mar 25, the value is -4.00. This value is below the healthy minimum of 5. It has decreased from -0.24 (Mar 24) to -4.00, marking a decrease of 3.76.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 58.39. This value exceeds the healthy maximum of 1. It has increased from 16.75 (Mar 24) to 58.39, marking an increase of 41.64.
- For Total Debt / Equity (X), as of Mar 25, the value is 58.39. This value exceeds the healthy maximum of 1. It has increased from 22.04 (Mar 24) to 58.39, marking an increase of 36.35.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.76 (Mar 24) to 0.15, marking a decrease of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 2.62, marking an increase of 0.78.
- For Quick Ratio (X), as of Mar 25, the value is 2.62. This value exceeds the healthy maximum of 2. It has increased from 1.84 (Mar 24) to 2.62, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.24. This value is below the healthy minimum of 3. It has decreased from 1.26 (Mar 24) to -0.24, marking a decrease of 1.50.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.87. This value is below the healthy minimum of 3. It has decreased from 0.88 (Mar 24) to -0.87, marking a decrease of 1.75.
- For Enterprise Value (Cr.), as of Mar 25, the value is -1.33. It has decreased from 10.82 (Mar 24) to -1.33, marking a decrease of 12.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is -0.62. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to -0.62, marking a decrease of 1.04.
- For EV / EBITDA (X), as of Mar 25, the value is 24.26. This value exceeds the healthy maximum of 15. It has increased from 22.58 (Mar 24) to 24.26, marking an increase of 1.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.32, marking an increase of 0.30.
- For Price / BV (X), as of Mar 25, the value is 6.13. This value exceeds the healthy maximum of 3. It has increased from 1.25 (Mar 24) to 6.13, marking an increase of 4.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.32, marking an increase of 0.30.
- For EarningsYield, as of Mar 25, the value is -0.60. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 24) to -0.60, marking a decrease of 0.53.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Covidh Technologies Ltd:
- Net Profit Margin: -19.64%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.65% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -372.77% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.87
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 133 (Industry average Stock P/E: 77.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 58.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -19.64%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | B-2, Plot: 797/A, Sai Krishna Building, Hyderabad Telangana 500033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Jayshree Suresh Jain | Managing Director |
| Mr. Jitendra Prabhakar | Executive Director |
| Mr. Mangina Srinivas Rao | Independent Director |
| Ms. Apurva Pradeep Joshi | Independent Director |
FAQ
What is the intrinsic value of Covidh Technologies Ltd?
Covidh Technologies Ltd's intrinsic value (as of 27 January 2026) is ₹2.19 which is 90.76% lower the current market price of ₹23.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹19.9 Cr. market cap, FY2025-2026 high/low of ₹23.7/1.90, reserves of ₹-0.43 Cr, and liabilities of ₹1.55 Cr.
What is the Market Cap of Covidh Technologies Ltd?
The Market Cap of Covidh Technologies Ltd is 19.9 Cr..
What is the current Stock Price of Covidh Technologies Ltd as on 27 January 2026?
The current stock price of Covidh Technologies Ltd as on 27 January 2026 is ₹23.7.
What is the High / Low of Covidh Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Covidh Technologies Ltd stocks is ₹23.7/1.90.
What is the Stock P/E of Covidh Technologies Ltd?
The Stock P/E of Covidh Technologies Ltd is 133.
What is the Book Value of Covidh Technologies Ltd?
The Book Value of Covidh Technologies Ltd is 0.13.
What is the Dividend Yield of Covidh Technologies Ltd?
The Dividend Yield of Covidh Technologies Ltd is 0.00 %.
What is the ROCE of Covidh Technologies Ltd?
The ROCE of Covidh Technologies Ltd is 19.0 %.
What is the ROE of Covidh Technologies Ltd?
The ROE of Covidh Technologies Ltd is %.
What is the Face Value of Covidh Technologies Ltd?
The Face Value of Covidh Technologies Ltd is 10.0.